The news: Hippocratic AI launched its Healthcare AI Agent App Store. Licensed US clinicians can design and create AI agents that carry out tasks like interacting with patients for chronic care management, procedure preparation, or post-discharge follow-up.
The rollout coincides with the startup’s $141 million Series B funding haul, which elevates Hippocratic to unicorn status at a valuation of $1.64 billion. Venture capital firm Kleiner Perkins led the round, with investors General Catalyst, Andreessen Horowitz, and Nvidia also participating, among others.
Here’s how it works: Clinicians can design an AI agent without any software programming knowledge and in less than 30 minutes. Safety testing by both the agent’s creator and Hippocratic staff follows. Each clinician has access to a dashboard that tracks their AI agent’s performance and shares feedback for further development.
Why it matters: Healthcare staffing shortages are creating challenges, and clinicians need ways to augment their workloads.
Our take: Hippocratic hopes that its App Store will help the company stand out in a crowded field of healthcare AI startups.
It’s enticing clinicians over to its platform by creating revenue-sharing opportunities. Clinicians are paid when their agents are used by Hippocratic’s customers.
This article is part of EMARKETER’s client-only subscription Briefings—daily newsletters authored by industry analysts who are experts in marketing, advertising, media, and tech trends. To help you finish 2024 strong, and start 2025 off on the right foot, articles like this one—delivering the latest news and insights—are completely free through January 31, 2025. If you want to learn how to get insights like these delivered to your inbox every day, and get access to our data-driven forecasts, reports, and industry benchmarks, schedule a demo with our sales team.